Late outcome after surgical and topical treatment for Aspergillus mediastinitis after heart transplantation.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Jul 2021
Historique:
revised: 04 01 2021
received: 28 10 2020
accepted: 09 02 2021
pubmed: 22 4 2021
medline: 11 6 2021
entrez: 21 4 2021
Statut: ppublish

Résumé

The 7-year long-term survival after Aspergillus fumigatus mediastinitis after heart transplantation, an uncommonly described condition, is herein reported. A 66-year-old male developed an infection with A. fumigatus covering the entire thoracic cavity with a fungal turf after orthotopic heart transplantation. Repeated surgical removal of infectious and necrotic tissue together with innovative topical treatment using voriconazole and chlorhexidine combined with systemic antifungal treatment, helped in controlling the infection. Definitive wound closure was achieved by standard sternal refixation and latissimus dorsi muscle flap plasty. Survival after A. fumigatus mediastinitis after heart transplantation was achieved with sequential debridement in combination with topical application of antifungal agents.

Identifiants

pubmed: 33880792
doi: 10.1111/jocs.15544
doi:

Substances chimiques

Voriconazole JFU09I87TR

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

2558-2561

Subventions

Organisme : The EurAsia Heart Foundation, Zürich, Switzerland
ID : There is no specific Grant number. The EurAsia Hea

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18:44-69.
Levin T, Suh B, Beltramo D, Samuel R. Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature. Transpl Infect Dis. 2004;6:129-131.
Chou NK, Wang JL, Chi NH, et al. Surgical treatment of mediastinitis after cardiac transplantation. Transplant Proc. 2008;40:2629-2630.
Forestier E, Remy V, Lesens O, et al. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole. Eur J Clin Microbiol. 2005;24:347-349.
Zbinden A, Imhof A, Wilhelm MJ, et al. Fatal outcome after heart transplantation caused by Aspergillus lentulus. Transpl Infect Dis. 2012;14:E60-E63.
Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327-360.
Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis. 2003;36:630-637.
Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408-415.
Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother. 2007;51:239-244.
Sen P, Gopal L, Sen PR. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series. Retina. 2006;26:935-939.
Jurkunas UV, Langston DP, Colby K. Use of voriconazole in the treatment of fungal keratitis. Int Ophthalmol Clin. 2007;47:47-59.
Formato A, Ottaviano A, Quarto G, Mozzillo N. Chlorhexidine gluconate in the treatment of subphrenic abscess and thoracic empyema. Minerva Chir. 1987;42(15-16):1271-1273.
Tortorano AM, Viviani MA, Biraghi E, Rigoni AL, Prigitano A, Grillot R. In vitro testing of fungicidal activity of biocides against Aspergillus fumigatus. J Med Microbiol. 2005;54:955-957.
Rahman MR, Johnson GJ, Husain R, Howlader SA, Minassian DC. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol. 1998;82:919-925.
Tekce AY, Erbay A, Cabadak H, Yagci S, Karabiber N, Sen S. Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline: a case report. Surg Infect. 2011;12:141-143.
Lachanas E, Tomos P, Sfyras N, Miyakis S, Kostakis A. Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review. Surg Infect. 2008;9:201-204.
George RS, Birks EJ, Haj-Yahia S, et al. Acinetobacter mediastinitis in a heart transplant patient. Ann Thorac Surg. 2006;82:715-716.
Jain RMS, Motukupally SR, Jain M. Use of topical colistin in multiple drug-resistant Pseudomonas aeruginosa bacterial keratitis. Cornea. 2014;33:923-927.

Auteurs

Paul R Vogt (PR)

Department of Cardiovascular Surgery, Klinik Im Park, Zürich, Switzerland.
Department of Cardiovascular Surgery, University Hospital Zürich, Zürich, Switzerland.

Raed Aser (R)

Department of Cardiovascular Surgery, University Hospital Zürich, Zürich, Switzerland.

Daniel Schmidlin (D)

Department of Anaesthesia and Intensive Care, Klinik Im Park, Zürich, Switzerland.

Paul Mohacsi (P)

Department of Cardiology, Klinik Im Park, Zürich, Switzerland.

Pascal A Berdat (PA)

Department of Cardiovascular Surgery, Klinik Im Park, Zürich, Switzerland.

Phillip Went (P)

Department of Pathology, Kantonsspital Graubünden, Chur, Switzerland.

Markus Flepp (M)

Department of Infectious Diseases, Klinik Im Park, Zürich, Switzerland.

Carlos A Mestres (CA)

Department of Cardiovascular Surgery, University Hospital Zürich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH